See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638833_2017_Surgery_Partners_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4610922076609507, 'aggregate_val': 959784000, 'exp_sum': 1780980000, 'exp_to_value': {'LaborExpense': 357175000, 'CostOfGoodsAndServicesSold': 821196000, 'GeneralAndAdministrativeExpense': 60246000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 330689000, 'DepreciationDepletionAndAmortization': 39551000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 172123000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638833, Surgery Partners Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 1,603,227,000 |
| 1 | AssetsNonCurrent | 16,435,000 |
| 2 | AssetsCurrent | 361,955,000 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 323,341,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 186,725,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 357,175,000 |
| 9 | CostOfGoodsAndServicesSold | 821,196,000 |
| 10 | GeneralAndAdministrativeExpense | 60,246,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 330,689,000 |
| 13 | DepreciationDepletionAndAmortization | 39,551,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -649,073,000 |
| 17 | remainder_Revenues | 1,145,438,000 |
| 18 | remainder_NetIncome | -100,571,000 |
| 19 | remainder_ComprehensiveNetIncome | -75,630,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,304,958,000 |
| 1 | Liabilities | 186,725,000 |
| 2 | Expenses | 959,784,000 |
| 3 | Revenues | 1,145,438,000 |
| 4 | StockholdersEquity | 2,118,233,000 |
| 5 | NetIncome | 85,083,000 |
| 6 | ComprehensiveNetIncome | 9,453,000 |
| 7 | BaseVar | 2,386,553,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.47 |
| 9 | EconomicCapitalRatio | 2.72 |